Navigation Links
Manufacturing antibodies
Date:3/18/2010

EUREKA project E! 3424 RECAN has developed a range of unique and highly specific monoclonal and polyclonal antibodies the proteins produced in the blood which counteract bacteria, viruses or cancerous cells. This was achieved by first producing a number of recombinant proteins which are important components of cellular signalling pathways. These proteins themselves have direct uses in immunisation and experimental studies. A further key advance is the incorporation of novel fluorochrome dyes with specific monoclonal antibodies, which can then be used in diagnosis of leukaemia and rheumatic diseases; also in oncology and haematology research.

The human immune system protects the body from disease by identifying and destroying the agents of disease bacteria, viruses and also its own cells if they become transformed into a potentially cancerous tumour. The immune system depends on the activity of antibodies, which are naturally produced within its white blood cells. The structure of antibodies has many millions of variations; each capable of recognising and marking a specific antigen, for example from a specific bacterium, so that the bacterium of that strain can be identified and destroyed by other types of white blood cells. If a molecule from a specific bacterium binds to a receptor protein on the surface of the white blood cell, the protein, which is an important component of the signalling pathway, triggers a response within the cell. In addition, antibodies can serve as an extremely useful research and diagnostic tool, as they can bind with great specificity and sensitivity to their target structures and then can be visualised by staining with specific dyes.

The Antibodies fabric

Modern molecular techniques now enable in vitro production of some of the receptor proteins. The RECAN project used recombinant techniques to produce them combining defined DNA sequences with the DNA of bacteria to alter the coding for specifi
'/>"/>

Contact: Piotr Pogorzelski
piotr.pogorzelski@es.eureka.be
322-777-0979
EUREKA
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Nanotube-producing bacteria show manufacturing promise
2. bioMETRX Expands Engineering and Manufacturing Capabilities
3. Caltech scientists create DNA tubes with programmable sizes for nanoscale manufacturing
4. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
5. Louisiana Techs Institute for Micromanufacturing to collaborate with colleagues in the arts
6. Synthetic molecules may be less expensive alternative to therapeutic antibodies, researchers find
7. Presence of certain antibodies signals healthier teeth and gums
8. 1918 flu antibodies resurrected from elderly survivors
9. Evolution in action: Our antibodies take evolutionary leaps to fight microbes
10. Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses
11. Scientists identify human monoclonal antibodies effective against bird and seasonal flu viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... in cellular DNA can endanger the whole organism, as ... at Ludwig-Maximilians-Universitaet (LMU) in Munich now report how byproducts ... helix. , The DNA in our cells controls the ... bodies. The instructions for this are encoded in the ... the bases adenine (A), cytosine (C), guanine (G) and ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
(Date:5/21/2013)... NC Biologists have known for a long time ... why isn,t well understood, particularly for plants. But it ... Lanfear of Australian National University and the U. S. ... to be published 21 May in the journal ... plants have faster-changing genomes. , Drawing from a database ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Small but speedy: Short plants live in the evolutionary fast lane 2
... , NEW YORK (February 24, 2012) A new ... Society, and others uses a new scientific methodology for ... "diversified portfolio" of management options from strict no-take ... methodology looks at existing information on the country,s climate, ...
... pm ET) Researchers have combined bioactive peptides to successfully ... published today in PLoS ONE , demonstrates that the ... and promotes re-growth of tissue. Further development of these peptides ... wounds. The team tested a newly-created peptide, UN3, ...
... from Karolinska Institutet in Sweden shows that a new ... ACR16 might operate via previously unknown mechanisms of ... ACR16 binds to the sigma-1 receptor, a protein in ... new knowledge can be used to develop future treatments ...
Cached Biology News:Study IDs new marine protected areas in Madagascar 2Novel bioactive peptides promote wound healing in vivo 2Novel bioactive peptides promote wound healing in vivo 3New knowledge on the pharmacology of dopamine stabilizers 2
(Date:5/24/2013)... The Oklahoma tornado left the state ... mayor of Moore, one of the heavily damaged towns, proposed ... from cnn.com. Reaching out to also be of help, My ... Shield to counter the looming mold problem. , The ... 2013, caused 24 deaths, My Cleaning Products shared. Ten of ...
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. (Nasdaq: ... focused on obtaining FDA clearance and commercializing its rapid, ... the pricing of an underwritten public offering of 10,000,000 ... purchase 3,500,000 shares of its common stock at an ... public offering price of $1.25 per share and related ...
(Date:5/23/2013)... SCHOFIELD, Wis. , May 23, 2013 /PRNewswire/ ... a researcher, developer, and marketer of over-the-counter (OTC) ... re-issued its research opinion on the company based ... Highlights , Non-Prescription, All Natural Product ... Show the Product Outperforms #1 Prescription Competitor ...
(Date:5/23/2013)... , May 23, 2013  Saddleback Memorial Medical ... recently became the first hospital on the West Coast ... This new surgical option provides women with a state-of-the-art, ... Marc Winter , M.D., a highly ... surgeon and medical director of minimally invasive surgery at ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a ... heart failure patients, today announced that, pursuant to Nasdaq ... fiscal year ended December 31, 2008, included in the ... 12, 2009, contained a going concern qualification from its ...
... Inc. (OTC Bulletin Board: TBIO) today announced financial results for ... Company,s financial results are presented in the tables that follow. ... loss of $219,000 or $0.00 per share for the fourth ... $212,000 or $0.00 per share for the fourth quarter of ...
... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX ), a ... drugs for the treatment of human viral diseases, today ... antiviral discovery and development programs have been accepted for ... Association for the Study of the Liver (EASL, April ...
Cached Biology Technology:Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 2Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 3Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 2Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 3Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 4Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 5Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 6Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 7Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results 8Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 2Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 3
... The Cetac Ultrasonic Nebulizers are available in two ... difference between these two models is that the ... to create a drier aerosol for improved detection ... detection limits for a range of elements by ...
...
... using a protein engineering approach that introduced amino ... wild-type DNase I. These changes markedly increase the ... is a versatile enzyme that has a 6-fold ... maintain at least 50% of peak activity in ...
... iTaq DNA polymerase is ... suitable for both conventional and ... is supplied at a concentration ... and includes 250 units polymerase, ...
Biology Products: